| 000 | 01692 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513184638.0 | ||
| 264 | 0 | _c19990701 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(98)00173-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSantoni, G | |
| 245 | 0 | 0 |
_aNeurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cJan 1999 |
||
| 300 |
_a15-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xchemistry |
| 650 | 0 | 4 |
_aCD5 Antigens _xanalysis |
| 650 | 0 | 4 |
_aCapsaicin _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aConcanavalin A _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInterleukin-2 _xbiosynthesis |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeurokinin-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aQuinuclidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-1 _ximmunology |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 650 | 0 | 4 |
_aSubstance P _xpharmacology |
| 700 | 1 | _aPerfumi, M C | |
| 700 | 1 | _aSpreghini, E | |
| 700 | 1 | _aRomagnoli, S | |
| 700 | 1 | _aPiccoli, M | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 93 _gno. 1-2 _gp. 15-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(98)00173-8 _zAvailable from publisher's website |
| 999 |
_c10337297 _d10337297 |
||